Deploying elements of scoping review methods for adverse outcome pathway development: a space travel case example.

AOP radiation risk assessment scoping review space flight health systematic evidence mapping

Journal

International journal of radiation biology
ISSN: 1362-3095
Titre abrégé: Int J Radiat Biol
Pays: England
ID NLM: 8809243

Informations de publication

Date de publication:
2022
Historique:
pubmed: 9 8 2022
medline: 25 11 2022
entrez: 8 8 2022
Statut: ppublish

Résumé

Health protection agencies require scientific information for evidence-based decision-making and guideline development. However, vetting and collating large quantities of published research to identify relevant high-quality studies is a challenge. One approach to address this issue is the use of adverse outcome pathways (AOPs) that provide a framework to assemble toxicological knowledge into causally linked chains of key events (KEs) across levels of biological organization to culminate in an adverse health outcome of significance to regulatory decision-making. Traditionally, AOPs have been constructed using a narrative review approach where the collection of evidence that supports each pathway is based on prior knowledge of influential studies that can also be supplemented by individually selecting and reviewing relevant references. We aimed to create a protocol for AOP weight of evidence gathering that harnesses elements of both scoping review methods and artificial intelligence (AI) tools to increase transparency while reducing bias and workload of human screeners. To develop this protocol, an existing space-health AOP in the workplan of the Organisation for Economic Co-operation and Development (OECD) AOP Programme was used as a case example. To balance the benefits of both scoping review tools and narrative approaches, a study protocol outlining a screening and search strategy was developed, and three reference collection workflows were tested to identify the most efficient method to inform weight of evidence. The workflows differed in their literature search strategies, and combinations of software tools used. Across the three tested workflows, over 59 literature searches were completed, retrieving over 34,000 references of which over 3300 were human reviewed. The most effective of the three methods used a search strategy with searches across each component of the AOP network, SWIFT Review as a pre-filtering software, and DistillerSR to create structured screening and data extraction forms. This methodology effectively retrieved relevant studies while balancing efficiency in data retrieval without compromising transparency, leading to a well-synthesized evidence base to support the AOP. The workflow is still exploratory in the context of AOP development, and we anticipate adaptations to the protocol with further experience. To further the systematicity, future iterations of the workflow could include structured quality assessment and risk of bias analysis. Overall, the workflow provides a transparent and documented approach to support AOP development, which in turn will support the need for rigorous methods to identify relevant scientific evidence while being practical to allow uptake by the broader community.

Identifiants

pubmed: 35939057
doi: 10.1080/09553002.2022.2110306
doi:

Types de publication

Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1777-1788

Auteurs

Tatiana Kozbenko (T)

Consumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, Canada.
Department of Biology, University of Ottawa, Ottawa, Canada.

Nadine Adam (N)

Consumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, Canada.

Vita Lai (V)

Consumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, Canada.

Snehpal Sandhu (S)

Consumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, Canada.

Jacqueline Kuan (J)

Consumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, Canada.

Danicia Flores (D)

Consumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, Canada.

Meghan Appleby (M)

Consumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, Canada.

Hanna Parker (H)

Department of Biology, University of Ottawa, Ottawa, Canada.

Robyn Hocking (R)

Consumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, Canada.

Katya Tsaioun (K)

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Carole Yauk (C)

Department of Biology, University of Ottawa, Ottawa, Canada.

Ruth Wilkins (R)

Consumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, Canada.

Vinita Chauhan (V)

Consumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH